KevinMD November 11, 2023
Catherine L. Chen, MD, MPH

I never imagined I’d be crying on vacation in Hawaii, but there I was, overwhelmed with worry because my 71-year-old mother’s Medicare Part B enrollment had been denied. A naturalized U.S. citizen, my mom had been living overseas with a rare blood cancer for 20 years. By December 2021, her end-stage disease required bi-weekly blood transfusions; the only hope for cure was a risky stem cell transplant. Therefore, in May 2022, she decided to return to the U.S. so my siblings and I could support her during treatment and recovery.

Since she had enrolled in Medicare Part A when she turned 65, as required, I assumed it would be straightforward to enroll her in Part B. After all, I’m a...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: CMS, Govt Agencies, Insurance, Medicare, Medicare Advantage, Patient / Consumer
Biden administration proposes Medicare coverage for weight loss drugs: 10 things to know
Proposed Coverage of Anti-Obesity Drugs in Medicare and Medicaid Would Expand Access to Millions of People with Obesity
Prior authorizations, pharmacy transparency, vertical integration all part of the Medicare 2026 rule
Medicare and Medicaid would cover Ozempic, Wegovy under new Biden rule
New Proposal Aims to Expand Medicaid and Medicare Coverage for Obesity Drugs

Share This Article